Address
Email address
Phone number
Website
Toome maale, müüme ja hooldame erinevaid meditsiiniseadmeid tunnustatud tootjatelt Philips Medical Systems, Abbott Laboratories, Laerdal jpt.
Name
AKTSIASELTS MEDITSIINIGRUPP
Registry code
10195499
VAT number
EE100668928
Type
AS - Joint Stock Company
Status
Registered
Foundation date
17.02.1997 (28)
Financial year
01.01-31.12
Capital
25 560.00 €
Activity
46462 - Wholesale of medical appliances and surgical and orthopaedic instruments and devices
-
-
-
-
-
-
-
No tax arrears
-
-
Owner | Representative | Beneficial owner | Roles | |
---|---|---|---|---|
Genoviir OÜ 10885436 | 100% - 25 560.00 EUR | - | - | Shareholder |
Toomas Värton
| - | Board member | - | |
Sirje Värton
| - | - | - | Board member |
Villu Valgi
| - | - | - | Board member |
Kristjan Värton
| - | - | - | Chairman of the board |
Silvi Sild
| - | - | - | Founder |
Owner | Representative | Beneficial owner | Roles | |
---|---|---|---|---|
Nanoviir OÜ 14122793 | - | - | - | Founder |
Medoviir OÜ 12364055 | - | - | - | Founder |
Turnover | State taxes | Labor taxes and payments | Employees | |
---|---|---|---|---|
2024 Q4 | 3 122 349.37 € | 375 219.96 € | 88 106.17 € | 18 |
2024 Q3 | 3 295 344.85 € | 561 881.8 € | 88 672.44 € | 19 |
2024 Q2 | 3 909 882.71 € | 456 969.25 € | 89 638.2 € | 19 |
2024 Q1 | 2 489 064.71 € | 346 318.32 € | 89 682.15 € | 19 |
2023 Q4 | 2 812 254.81 € | 325 868.72 € | 77 356.71 € | 20 |
2023 Q3 | 2 324 677.01 € | 263 659.89 € | 76 799.53 € | 18 |
2023 Q2 | 3 124 460.85 € | 352 033.04 € | 69 779.38 € | 18 |
2023 Q1 | 3 241 895.55 € | 370 985.35 € | 66 465.6 € | 17 |
2022 Q4 | 3 788 466.78 € | 436 829.68 € | 63 810.86 € | 18 |
2022 Q3 | 2 478 536.02 € | 279 766.69 € | 61 218.17 € | 17 |
2022 Q2 | 3 892 509.31 € | 479 953.23 € | 61 859.59 € | 17 |
2022 Q1 | 4 559 468.56 € | 596 616.5 € | 64 969.84 € | 17 |
2021 Q4 | 4 554 188.42 € | 506 467.35 € | 57 251.71 € | 17 |
2021 Q3 | 2 564 875.6 € | 161 312.58 € | 58 803.23 € | 18 |
2021 Q2 | 2 018 777.12 € | 232 063.17 € | 70 337.36 € | 17 |
2021 Q1 | 2 490 827.74 € | 311 461.56 € | 61 638.63 € | 19 |
2020 Q4 | 3 809 817.23 € | 436 456.24 € | 59 273.21 € | 18 |
2020 Q3 | 2 742 042.81 € | 407 778.04 € | 63 127.78 € | 19 |
2020 Q2 | 4 755 567.38 € | 596 566.74 € | 64 726.86 € | 19 |
2020 Q1 | 2 322 697.51 € | 299 267.51 € | 60 245.5 € | 20 |